August 2, 2012
Blood Cancer Drug Effective in Treating Kidney, Breast Cancer
Two drugs approved by the Food and Drug Administration for blood cancer treatment may also be used to treat triple negative breast and kidney cancer, researchers say. The drugs are romidepsin and decitabine. Together they can activate a gene sFRP1 (secreted frizzled related protein one) that can stop the growth of cancer cells. “We now […]
Tags: decitabine, Dr. John Copland, FDA, Medical Daily, romidepsin